TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

Journal of Experimental Medicine

Volumn 191, Issue 3, 2000, Pages 495-501

  Josien, Régis ^a,c   Li, Hong Li ^a   Ingulli, Elizabeth ^b   Sarma, Supria ^a   Wong, Brian R ^a   Vologodskaia, Maria ^a   Steinman, Ralph M ^a   Choi, Yongwon ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Dendritic cells; Immunization; T cell; TRANCE

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNOTHERAPY; LONGEVITY; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARRIER PROTEINS; CD40 LIGAND; CELL COUNT; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FLUORESCEINS; FLUORESCENT DYES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; T-LYMPHOCYTES; TIME FACTORS; TUBERCULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034614892     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.3.495     Document Type: Article

References (33)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Dendritic cells and the control of immunity
3. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
4. Migration patterns of dendritic cells in the mouse: Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues
5. + T cells
6. Lymph-borne dendritic leukocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells
7. Characterization of nonlymphoid cells derived from rat peripheral lymph
8. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
9. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
10. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
11. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells
12. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
13. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
14. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
15. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
16. Developmental regulation of MHC class II transport in mouse dendritic cells
17. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes
18. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
19. Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ
20. +TCR(lo) thymocytes in vivo
21. + T cells in vivo by IL-15
22. + T cells
23. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation
24. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
25. From TCR engagement to T cell activation: A kinetic view oft cell behavior
26. Dendritic cells require maturation via CD40 to generate protective antitumor immunity
27. + T-helper and a T-killer
28. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
29. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
30. Active specific T-cell-based immunotherapy for cancer: Nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects
31. Dendritic cells as adjuvants for immune-mediated resistance to tumors
32. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
33. Migration of human dendritic cells after injection in patients with metastatic malignancies